CLINICAL_TRIALS
research
· 2016-12-16
Clinical Trial Update: Patient Perception Study for AL-4943A [Phase 4]
Summary
Alcon's Phase 4 patient-perception study of AL-4943A for allergic conjunctivitis has completed, per the trial registry update.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 4 | Status: COMPLETED